Enzyme-linked Immunosorbent Assay Market - Top Companies and Manufacturers

  • Report ID: 5526
  • Published Date: May 07, 2024
  • Report Format: PDF, PPT

Companies Dominating the Enzyme-linked Immunosorbent Assay Landscape

top-features-companies
    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Neogen Corporation
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG
    • BD (Becton, Dickinson and Company)
    • Agilent Technologies, Inc.
    • BioMérieux SA
    • Ortho Clinical Diagnostics

Browse Key Market Insights with Data Illustration:

In the News

  • Neogen Corporation declared an innovative Veratox VIP assay for recognizing Cashew, the second test in Neogen's new line of enhanced quantitative ELISA products. 
  • Siemens Healthineers announced that the SARSCoV2 IgG Antibody Test can evaluate neutralizing antibodies, which is the reason behind its receiving CE marking. This test is the better version of its previously launched COVID-19 antibody testing.

Author Credits:  Radhika Pawar


  • Report ID: 5526
  • Published Date: May 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of enzyme-linked immunosorbent assay was over USD 12 billion.

The market size for enzyme-linked immunosorbent assay is projected to cross USD 27 billion by the end of 2036 expanding at a CAGR of 6% during the forecast period i.e., between 2024-2036.

The major players in the market are F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, BD (Becton, Dickinson and Company), Agilent Technologies, Inc., BioMérieux SA, Ortho Clinical Diagnostics, and others.

In terms of type, the sandwich ELISA segment is anticipated to account for the largest market share of 62% during 2024-2036.

The North American enzyme-linked immunosorbent assay sector is poised to hold the highest share of 35% by 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying